학술논문

Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
Document Type
Article
Source
In Blood Advances 25 April 2023 7(8):1460-1476
Subject
Myeloid Neoplasia
Hematopoiesis and Stem Cells
Language
ISSN
2473-9529